Form 4: Director Boosts Stake in Scholar Rock Holding Corp

Srinivas Akkaraju, a director at Scholar Rock Holding Corp, significantly increased his indirect beneficial ownership through multiple purchases and warrant exercises by affiliated funds.

Summary

• Srinivas Akkaraju, a director of Scholar Rock Holding Corp (SRRK), reported several transactions increasing his indirect beneficial ownership through affiliated entities.
• On October 7, 2025, Samsara Opportunity Fund, L.P., an entity over which Mr. Akkaraju has voting and investment power, purchased a total of 29,599 shares of Common Stock in three separate transactions.
• These purchases were made at weighted average prices of $39.31 (12,796 shares), $40.18 (12,400 shares), and $40.97 (4,403 shares).
• Following these purchases, Samsara Opportunity Fund, L.P. beneficially owned 530,038 shares.
• On December 12, 2025, Samsara BioCapital, L.P., another entity over which Mr. Akkaraju has voting and investment power, exercised warrants to acquire 1,064,804 shares of Common Stock at an exercise price of $7.35 per share.
• Following this warrant exercise, Samsara BioCapital, L.P. beneficially owned 6,367,614 shares.
• The filing also reported a disposition of 21,132 shares of Common Stock, though specific transaction date, code, price, and resulting beneficial ownership details were not provided for this particular entry.
• Mr. Akkaraju disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.

Sentiment

Score: 8

Explanation: The significant increase in indirect beneficial ownership by a director through both open market purchases and warrant exercises indicates strong confidence in the company's future prospects. The warrant exercise at a low strike price is particularly bullish, outweighing the minor disposition with incomplete details.

Positives

• Director Srinivas Akkaraju, through Samsara Opportunity Fund, L.P., purchased 29,599 shares of Common Stock on October 7, 2025, at weighted average prices between $39.31 and $40.97, increasing the fund's beneficial ownership to 530,038 shares.
• Samsara BioCapital, L.P., also controlled by Mr. Akkaraju, exercised warrants on December 12, 2025, to acquire 1,064,804 shares of Common Stock at an exercise price of $7.35, significantly increasing its beneficial ownership to 6,367,614 shares.
• These transactions collectively represent a substantial increase in the director's indirect stake in the company, signaling strong confidence in its future prospects.

Negatives

• The filing reported a disposition of 21,132 shares of Common Stock without providing specific details such as the transaction date, price, or the resulting beneficial ownership, which introduces a minor lack of transparency for that particular transaction.

Risks

• The filing itself does not explicitly mention risks. However, the nature of the transactions (purchases and warrant exercises) implies market risk associated with holding equity securities.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance, but the significant insider buying and warrant exercise suggest a positive long-term outlook from the reporting person and affiliated funds.

Industry Context

Insider buying, particularly by a director, can signal confidence in a company's future prospects, which is often viewed positively in the biotechnology sector where R&D milestones and clinical trial results heavily influence stock performance. Such transactions by affiliated investment funds suggest a strategic long-term investment perspective.

Comparison to Industry Standards

• Not applicable. This filing reports insider transactions and does not contain performance metrics or project results for comparison.

Related Party Transactions

• Srinivas Akkaraju, a director of Scholar Rock Holding Corp, has voting and investment power over Samsara Opportunity Fund, L.P. and Samsara BioCapital LP, which are the entities directly holding the securities. These transactions represent indirect beneficial ownership by a related party (the director).

Stakeholder Impact

• Shareholders: The significant insider buying could be interpreted as a positive signal, potentially boosting investor confidence and share price.
• Management: Reinforces alignment of interests between management (via director) and shareholders.

Next Steps

• The filing does not explicitly mention future actions, events, or milestones for the company, but the reporting person undertakes to provide full information regarding the number of securities purchased at each separate price within the reported ranges upon request.

Key Dates

Recommendation

The substantial increase in indirect beneficial ownership by a director, through both open market purchases at varying price points and the exercise of a large block of warrants at a significantly lower strike price, signals strong conviction in Scholar Rock Holding Corp's future. This insider activity suggests that the director and affiliated funds believe the stock is undervalued or has significant upside potential, making it a compelling 'strong buy' signal for seasoned investors.

Keywords

Scholar Rock Holding Corp, SRRK, Form 4, Insider Buying, Director Purchases, Warrant Exercise, Srinivas Akkaraju, Samsara Opportunity Fund, Samsara BioCapital, Biotechnology, SEC Filing, Beneficial Ownership